Peter Kolkhof

15PUBLICATIONS
67CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Epidemiological modellingNeurology and neuromuscular diseasesCharacterisation of biological macromoleculesMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 30, 2026
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

|Sep 29, 2024
Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF.

Misato Chimura, Mark C Petrie, Morten Schou

|Sep 01, 2024
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes.

Muthiah Vaduganathan, Gerasimos Filippatos, Brian L Claggett

|Jun 11, 2024
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.

Hiddo J L Heerspink, Rajiv Agarwal, George L Bakris

|Jun 06, 2024
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease.

Ixchel Lima Posada, Matthieu Soulié, Yohan Stephan

|Feb 11, 2023
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction.

Ixchel Lima-Posada, Yohan Stephan, Matthieu Soulié

Pageof 3

Frequent Collaborators

5 joint publications

Peter Rossing

4 joint publications

Faiez Zannad

4 joint publications

Carolyn S P Lam

3 joint publications

Michele Senni